These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15651411)

  • 1. [Bacterial RND-type multicomponent efflux systems: the efflux systems involved in production of pathogenic factors as well as resistance to antimicrobial agents].
    Gotoh N
    Tanpakushitsu Kakusan Koso; 2005 Jan; 50(1):6-12. PubMed ID: 15651411
    [No Abstract]   [Full Text] [Related]  

  • 2. mvaT mutation modifies the expression of the Pseudomonas aeruginosa multidrug efflux operon mexEF-oprN.
    Westfall LW; Carty NL; Layland N; Kuan P; Colmer-Hamood JA; Hamood AN
    FEMS Microbiol Lett; 2006 Feb; 255(2):247-54. PubMed ID: 16448502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efflux as a mechanism of resistance to antimicrobials in Pseudomonas aeruginosa and related bacteria: unanswered questions.
    Schweizer HP
    Genet Mol Res; 2003 Mar; 2(1):48-62. PubMed ID: 12917802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance against antimicrobial peptides is independent of Escherichia coli AcrAB, Pseudomonas aeruginosa MexAB and Staphylococcus aureus NorA efflux pumps.
    Rieg S; Huth A; Kalbacher H; Kern WV
    Int J Antimicrob Agents; 2009 Feb; 33(2):174-6. PubMed ID: 18945595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the las and rhl quorum-sensing systems in clinical isolates of Pseudomonas aeruginosa does not correlate with efflux pump expression or antimicrobial resistance.
    Bratu S; Gupta J; Quale J
    J Antimicrob Chemother; 2006 Dec; 58(6):1250-3. PubMed ID: 17030516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of the multidrug efflux pumps MexCD-OprJ and MexEF-OprN is associated with a reduction of type III secretion in Pseudomonas aeruginosa.
    Linares JF; López JA; Camafeita E; Albar JP; Rojo F; Martínez JL
    J Bacteriol; 2005 Feb; 187(4):1384-91. PubMed ID: 15687203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrinsic resistance of Escherichia coli to mureidomycin A and C due to expression of the multidrug efflux system AcrAB-TolC: comparison with the efflux systems of mureidomycin-susceptible Pseudomonas aeruginosa.
    Gotoh N; Murata T; Ozaki T; Kimura T; Kondo A; Nishino T
    J Infect Chemother; 2003 Mar; 9(1):101-3. PubMed ID: 12673418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of cell wall organization and active efflux pump systems in multidrug resistance of bacteria].
    Hasdemir U
    Mikrobiyol Bul; 2007 Apr; 41(2):309-27. PubMed ID: 17682720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The phenazine pyocyanin is a terminal signalling factor in the quorum sensing network of Pseudomonas aeruginosa.
    Dietrich LE; Price-Whelan A; Petersen A; Whiteley M; Newman DK
    Mol Microbiol; 2006 Sep; 61(5):1308-21. PubMed ID: 16879411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of the MexXY-OprM efflux system in emergence of cefepime resistance in clinical strains of Pseudomonas aeruginosa.
    Hocquet D; Nordmann P; El Garch F; Cabanne L; Plésiat P
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1347-51. PubMed ID: 16569851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple genotypic changes in hypersusceptible strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients do not always correlate with the phenotype.
    Wolter DJ; Black JA; Lister PD; Hanson ND
    J Antimicrob Chemother; 2009 Aug; 64(2):294-300. PubMed ID: 19468029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efflux pump inhibitors reduce the invasiveness of Pseudomonas aeruginosa.
    Hirakata Y; Kondo A; Hoshino K; Yano H; Arai K; Hirotani A; Kunishima H; Yamamoto N; Hatta M; Kitagawa M; Kohno S; Kaku M
    Int J Antimicrob Agents; 2009 Oct; 34(4):343-6. PubMed ID: 19615866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An RND-type multidrug efflux pump SdeXY from Serratia marcescens.
    Chen J; Kuroda T; Huda MN; Mizushima T; Tsuchiya T
    J Antimicrob Chemother; 2003 Aug; 52(2):176-9. PubMed ID: 12837741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contributions of efflux pumps to high level resistance of Pseudomonas aeruginosa to ciprofloxacin.
    Wang DD; Sun TY; Hu YJ
    Chin Med J (Engl); 2007 Jan; 120(1):68-70. PubMed ID: 17254491
    [No Abstract]   [Full Text] [Related]  

  • 15. MexAB-OprM- and MexXY-overproducing mutants are very prevalent among clinical strains of Pseudomonas aeruginosa with reduced susceptibility to ticarcillin.
    Hocquet D; Roussel-Delvallez M; Cavallo JD; Plésiat P
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1582-3. PubMed ID: 17220417
    [No Abstract]   [Full Text] [Related]  

  • 16. Altered spectrum of multidrug resistance associated with a single point mutation in the Escherichia coli RND-type MDR efflux pump YhiV (MdtF).
    Bohnert JA; Schuster S; Fähnrich E; Trittler R; Kern WV
    J Antimicrob Chemother; 2007 Jun; 59(6):1216-22. PubMed ID: 17062614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A critical step for relative quantification of mRNAs is selecting the correct internal controls.
    Vahaboglu H
    FEMS Microbiol Lett; 2005 Apr; 245(1):191-2. PubMed ID: 15796998
    [No Abstract]   [Full Text] [Related]  

  • 18. Regulation of virulence and antibiotic resistance by two-component regulatory systems in Pseudomonas aeruginosa.
    Gooderham WJ; Hancock RE
    FEMS Microbiol Rev; 2009 Mar; 33(2):279-94. PubMed ID: 19243444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug screening model acting on out-membrane protein OprM in pseudomonas aeruginosa efflux pump system].
    Tian R; Yu LY; Xiao CL; Zuo L; Yao TJ; Yang LX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Aug; 26(4):359-63. PubMed ID: 15379256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virulence and drug resistance roles of multidrug efflux systems of Salmonella enterica serovar Typhimurium.
    Nishino K; Latifi T; Groisman EA
    Mol Microbiol; 2006 Jan; 59(1):126-41. PubMed ID: 16359323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.